Study Of Sunitinib With FOLFIRI In Colorectal Cancer
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, safety and pharmacokinetics of sunitinib plus FOLFIRI (irinotecan,
5-FU and l-leucovorin) in the first-line treatment of Japanese mCRC patients